Galectin Therapeutics' IPO

Galectin Therapeutics raised a round of funding on November 07, 2003. Investors include Public.

Galectin Therapeutics (OTC: PRWP), formerly Pro-Pharmaceuticals, is developing promising carbohydrate-based therapies for fibrotic liver disease and cancer based on the company's unique understanding …

Articles about Galectin Therapeutics' IPO: